The cryogenic container held twenty-four embryos.
Federal agents transferred it under armed escort to a secure reproductive-medicine laboratory.
No one knew immediately where the embryos had come from.
Some had donor codes.
Some had only numbers.
Three carried the Hale-series designation.
Samuel asked to see the genetic profiles.
Bell refused until a warrant permitted investigators to use him as a consultant.
When Samuel finally reviewed them, his face became unreadable.
“Vale edited them.”
Dr. Shah stood across the table.
“For what?”
“Not merely cancer susceptibility.”
He pointed to several sequences.
The embryos had been altered to carry synthetic receptor systems from conception.
No infant injection would be necessary.
No later integration uncertainty.
The modification would exist in nearly every cell.
Daniel stared.
“That would make the immune therapy attack everything.”
“Not if Vale redesigned the receptor control.”
“Did he?”
Samuel studied the sequence.
“He tried.”
Claire hated the word tried.
Human embryos were being used to test whether he had succeeded.
Bell’s reproductive-crimes specialists traced the donor codes.
Several appeared connected to fertility clinics whose databases had been breached.
Two clinics denied transferring any embryos.
One discovered frozen material missing.
The crime had expanded again.
Sophie listened only to the parts Claire allowed.
When she understood enough, she asked one question.
“Are those babies?”
Claire sat beside her.
“They’re embryos. They haven’t developed into babies.”
“Are they alive?”
“In a biological sense, yes.”
Sophie frowned.
“Can Vale make them into people?”
“Not by himself.”
“He needs someone with a pregnancy.”
Claire nodded.
Sophie looked disgusted.
“He’s really weird.”
That was the safest description available.
Eric’s protective cellular factors continued to produce promising laboratory results.
When added to healthy Sophie-derived cells, receptor expression fell dramatically under inflammatory stress.
Tumor cells remained visible.
Dr. Shah showed Claire the graph.
“This may make the infusion substantially safer.”
“May.”
“Yes.”
Claire had learned not to demand certainty medicine could not provide.
“What happens next?”
“We manufacture a small regulatory-cell product from Eric’s sample.”
“How long?”
“Normally, weeks.”
Claire stared.
“We don’t have weeks.”
“No.”
The team proposed an emergency alternative.
Rather than manufacture a full cell product, they could isolate specific extracellular signaling molecules from Eric’s cells and administer them under controlled conditions.
Experimental.
Unproven.
But testable.
Samuel objected.
“Too transient.”
Dr. Shah turned.
“You do not make treatment decisions.”
“I am telling you the effect will disappear too quickly.”
“And I am telling you we can repeat dosing if necessary.”
Samuel shook his head.
“You’ll create fluctuating receptor suppression.”
“Which is preferable to systemic healthy-tissue targeting.”
Samuel started to respond.
Sophie raised her hand.
Both doctors stopped.
“You’re arguing about me.”
“Yes,” Shah said.
“Can you do it somewhere else?”
Dr. Shah almost smiled.
“Yes.”
“Good.”
They left.
Sophie looked at Claire.
“I like Dr. Shah.”
“So do I.”
“I don’t like Grandpa.”
“That makes two of us.”
“More than two.”
“Probably.”
The planned cellular infusion was delayed another twelve hours while Eric’s protective factors were prepared.
Sophie complained.
Claire understood.
Every delay felt like giving Kevin more time.
But new MRI imaging showed the brain lesion had not grown significantly since diagnosis.
They had room to be careful.
Barely.
That afternoon Bell brought another development.
Investigators had decrypted Vale’s embryo database.
One file contained genetic-source information.
Bell asked Claire and Eric to meet privately.
Daniel came too.
“No more private family secrets,” Claire said.
Bell agreed.
He displayed a donor map.
Some embryos used anonymous donor material.
Others used DNA sequences derived from research subjects.
Sophie’s sequence appeared in simulations, but no embryo contained her reproductive material.
Claire exhaled.
Then Bell scrolled.
A maternal-source reference appeared.
CLAIRE MORGAN.
Claire stared.
“No.”
Eric leaned toward the screen.
“That can’t be right.”
Bell looked at Claire.
“Have you ever undergone fertility treatment?”
“No.”
“Egg retrieval?”
“No.”
“Genetic testing?”
“During pregnancy. Routine prenatal screening.”
“Anything else?”
Claire thought.
Years earlier, before Sophie, she had participated in a university women’s-health study.
Blood sample.
Saliva.
Nothing involving eggs.
Bell asked the university.
The study’s genetic database had been administered by a contractor.
NorthStar Medical Logistics.
Claire laughed once.
Of course.
“They had my DNA before Sophie was born.”
“Yes.”
“Samuel knew I was pregnant before Eric told him.”
Bell nodded.
“That may be how.”
Eric stared at his father through the glass.
“You selected Claire too.”
Samuel shook his head.
“No.”
“You had her genetic data.”
“I did not.”
“You knew she was pregnant.”
“Yes.”
“How?”
Samuel hesitated.
Claire’s anger rose.
“Answer.”
“Leonard told me.”
Price.
NorthStar already monitored the family.
Samuel claimed he initially rejected Sophie as a candidate because Claire did not carry the Hale mutation.
Then he realized that was precisely why Sophie was scientifically valuable.
She could inherit Eric’s risk variant against a genetically unrelated maternal background.
A cleaner comparison.
Claire stood.
“You are describing my daughter like a laboratory cross.”
Samuel lowered his eyes.
“That is how I thought then.”
“And now?”
“Now she is Sophie.”
Claire laughed bitterly.
“She was always Sophie.”
Samuel had no answer.
Bell returned to Vale’s embryo files.
Claire’s DNA had been used computationally, not physically.
Vale had modeled how her genetic background influenced Sophie’s response.
One embryo sequence, however, had been designed to recreate Sophie’s genetic combination as closely as possible using other donors.
Daniel stared.
“He’s trying to make another Sophie.”
Samuel shook his head.
“Not another Sophie.”
“What would you call it?”
“A controlled replication.”
Daniel stepped toward him.
Claire caught Daniel’s arm.
“Don’t.”
Samuel seemed to realize how monstrous the phrase sounded only after saying it.
Sophie’s biology had become a blueprint.
Phase Three intended to create children already carrying the engineered system, then follow them from birth.
No accidental vector integration.
No uncertain inheritance.
No need to hunt genetically suitable children later.
Vale wanted to industrialize the experiment.
Bell’s team urgently traced fertility specialists associated with him.
One name appeared repeatedly.
Dr. Melissa Grant.
A reproductive endocrinologist whose clinic had closed unexpectedly six months earlier.
Grant had disappeared.
Her bank accounts showed regular payments from a NorthStar shell company.
Samuel recognized her too.
“She worked with Vale.”
“Doing what?”
“Embryo screening.”
Bell immediately issued a nationwide alert.
The next breakthrough came from an unexpected source.
Leonard Price woke.
He remained hospitalized under guard after surviving the poison he had taken.
Doctors allowed a short interview.
Bell joined remotely.
Claire listened from Sophie’s secure room.
Price’s voice was weak.
“Vale took Phase Three from us.”
Bell leaned closer.
“Us?”
“NorthStar.”
“You authorized it.”
“Early development. Not implantation.”
“Why draw the line there?”
Price coughed.
“Because altering existing patients can be treated as therapy. Creating children around an experiment is something else.”
Daniel muttered, “That is an impressively late moral boundary.”
Price heard him.
“I’m not asking forgiveness.”
“Good.”
Bell asked where Grant was.
Price did not know.
But Vale had repeatedly mentioned a private clinic outside the United States.
No regulatory oversight.
Commercial surrogacy.
Embryo transfer.
Claire’s stomach turned.
“Has he implanted any?”
Price closed his eyes.
“I don’t know.”
Samuel interrupted.
“Leonard.”
Price’s expression changed at the sound of his voice.
“You should be dead.”
“You tried.”
“Not hard enough.”
Bell cut them off.
“Where would Vale take the embryos?”
Price hesitated.
“Ask Samuel about Meridian.”
Samuel went completely still.
Claire saw it.
“What is Meridian?”
Samuel refused to answer.
Bell leaned toward him.
“Samuel.”
“It was never built.”
Price laughed weakly.
“Another thing you were wrong about.”
“What is it?” Claire demanded.
Samuel finally answered.
Meridian had been a proposal for an independent offshore research facility.
A place where experimental gene therapies could be developed outside conventional institutional oversight.
Samuel had designed it twenty years earlier.
He claimed he abandoned the project after Maya died.
Price claimed NorthStar later financed part of it.
“Where?” Bell asked.
Price gave coordinates.
Not offshore.
A remote private medical compound in the Caribbean operating under a different name.
Bell’s face tightened.
International jurisdiction complicated everything.
Calls began.
State Department.
Foreign authorities.
Interpol contacts.
Claire listened to the machinery of governments waking around her daughter’s stolen biology.
Sophie tugged her sleeve.
“Are we going somewhere?”
“No.”
“Good. I’m tired.”
The treatment team entered an hour later.
Eric’s protective factors were ready.
Sophie’s engineered immune cells had passed independent testing.
The correct suicide switch worked.
The receptor-binding sequence matched the intended therapeutic construct.
Dr. Shah sat beside Sophie.
“We can proceed tomorrow morning.”
Sophie looked at Claire.
“No more delays?”
“Not unless something changes.”
Sophie nodded.
“Okay.”
Then she looked at Eric.
“You gave them the good blood?”
“So they tell me.”
“Thanks.”
Eric smiled.
“You’re welcome.”
That evening Daniel sat beside Sophie while Claire showered.
When she returned, both were asleep.
Sophie’s head rested against his shoulder.
Daniel’s hand still held the fantasy novel open.
Claire took a photograph on a secure hospital camera.
No cloud backup.
No compromised phone.
Just a moment preserved locally.
Eric appeared at the doorway.
“She looks peaceful.”
“For once.”
He watched them.
“I used to resent him.”
Claire looked at Eric.
“Daniel?”
“Yes.”
“I noticed.”
“He got all the ordinary parts.”
Claire understood.
School pickups.
Soccer.
Dentist appointments.
Burned pancakes.
Bedtime.
Things Eric had treated as small until extraordinary circumstances revealed their value.
“I thought biology meant I could always come back and still occupy the same place.”
Claire said nothing.
Eric looked at Sophie.
“It doesn’t.”
“No.”
“He’s her father.”
“Yes.”
Eric nodded.
“So am I.”
Claire looked at him.
“Yes.”
For once the statement contained no competition.
Near midnight, Bell received confirmation from Caribbean authorities.
The Meridian facility existed.
Officially it was called the Meridian Reproductive Wellness Institute.
Private.
Expensive.
Heavily secured.
Dr. Melissa Grant had entered the country four days earlier.
Nathan Vale arrived the following day.
A refrigerated shipment from NorthStar landed twelve hours after that.
The embryos.
Bell looked at Claire.
“We believe they’re there.”
“Can authorities seize them?”
“They’re preparing a warrant under local law.”
“How long?”
“Hours.”
Sophie’s infusion was scheduled for seven in the morning.
At 3:26, Bell’s secure phone rang.
Meridian had been raided.
Vale escaped again.
Grant was arrested.
The cryogenic container was recovered.
Twenty-three embryos remained.
Claire sat upright.
“Twenty-three?”
Bell nodded.
“One is missing.”
Samuel closed his eyes.
Price, listening from his hospital room, whispered something Bell almost missed.
“Too late.”
Claire felt her pulse accelerate.
“What does that mean?”
Grant initially refused to speak.
Then investigators confronted her with the missing embryo record.
She broke.
The embryo had not been destroyed.
It had been transferred.
Three days earlier.
“To whom?” Bell asked.
Grant looked at the floor.
“A surrogate.”
Claire felt cold.
“Where is she?”
Grant gave a name.
A young woman from Florida.
Elena Ruiz.
Bell immediately searched travel records.
Elena had left Meridian the previous morning.
Her destination was the United States.
She had already landed.
Claire looked at Samuel.
“Was the transfer successful?”
Grant had performed testing before Elena departed.
The answer arrived minutes later.
Positive implantation markers.
Samuel sat silently.
Vale had done it.
Phase Three was no longer frozen inside a laboratory container.
Somewhere in the country, a woman was carrying an embryo designed from the same research that had transformed Sophie’s body into an experiment.
Click here to continue reading: PART 15: Sophie Entered the Most Dangerous Hours of Her Treatment as Agents Found the Surrogate and Learned Vale Had Lied About Her Pregnancy
The Nurse Stopped Smiling Before She Closed the Door, and Claire Knew Sophie’s Routine Blood Test Had Found Something Wrong
Part 14 of 47
